1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0908
    Ginsenoside Rg5

    人参皂甙 Rg5

    Inhibitor 99.88%
    Ginsenoside Rg5 是红参的主要成分,是 IGF-1R 的竞争型激动剂。Ginsenoside Rg5 竞争 IGF-1R 的结合位点,并阻断 IGF-1IGF-1R 的结合 (IC50 约为 90 nM)。Ginsenoside Rg5 还通过抑制 NF-κB p65 的 DNA 结合活性来抑制 COX-2mRNA 表达。
    Ginsenoside Rg5
  • HY-108039
    Bezisterim Inhibitor
    Bezisterim (HE 3286; NE-3107) 是天然抗炎类固醇 β-AET 的合成衍生物。Bezisterim 是具有口服活性的 NF-κB 部分抑制剂。Bezisterim 降低了促炎信号,包括 IL-6 和基质金属肽酶 3。Bezisterim 可自由穿过小鼠血脑屏障。Bezisterim 可用于溃疡性结肠炎、关节炎、实验性自身免疫性脑脊髓炎的研究。Bezisterim 是一种点击化学试剂。它含有 Alkyne 基团,可以和含有 Azide 基团的分子发生铜催化的叠氮-炔环加成反应 (CuAAc)。
    Bezisterim
  • HY-121389
    Hexadecanamide

    十六碳酰胺

    Inhibitor
    Hexadecanamide (Palmitamide) 是一种脂肪酸酰胺,具有口服抗过敏、抗氧化和神经保护作用。Hexadecanamide对金黄色葡萄球菌 (Staphylococcus aureus) 和 SARA 诱发的乳腺炎具有保护作用。Hexadecanamide 可抑制金黄色葡萄球菌诱导的 NF-κB 通路激活,并改善血乳屏障的完整性。Hexadecanamide 可激活 PPARα。Hexadecanamide 可在体外增强精子活力。Hexadecanamide 可用于乳腺炎和弱精子症的研究。
    Hexadecanamide
  • HY-B0185R
    Lidocaine (Standard)

    利多卡因(标准品)

    Inhibitor
    Lidocaine (Standard) 是 Lidocaine 的分析标准品。本产品用于研究及分析应用。Lidocaine (Lignocaine) 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物,可用于研究室性心律失常。
    Lidocaine (Standard)
  • HY-N0436
    Engeletin

    黄杞苷

    Inhibitor 99.88%
    Engeletin 是从 Smilax glabra Roxb. 中得到的黄酮苷类物质,能够抑制 NF-κB 信号通路的激活,具有抗炎、缓解疼痛、利尿、消肿、抗菌等作用。
    Engeletin
  • HY-N0408
    Picroside II

    胡黄连苷II

    Inhibitor 99.91%
    Picroside II 是一种可口服的抗氧化剂,可以减少 ROS 产生和保护 (CI/R) 损伤后的血脑屏障 (BBB),具有神经保护作用。Picroside II 具有抗氧化,免疫调节,抗病毒,抑制细胞凋亡活性,并通过抑制 NLRP3 炎性体和 NF-κB 通路的激活,减轻脓毒症的炎症反应。
    Picroside II
  • HY-N6602
    α-Solanine

    α-茄碱

    Inhibitor 99.89%
    α-solanine 是Solanum nigrum中的一种生物活性成分,是主要的甾体类生物碱之一,可抑制癌细胞的生长并诱导其凋亡 (apoptosis)。
    α-Solanine
  • HY-110195
    Smurf1-IN-A01 99.81%
    Smurf1-IN-A01 是一个 Smurf1 抑制剂, Smurf1-IN-A01 具有抗癌活性,可用于骨质疏松和年龄相关性黄斑变性的研究。
    Smurf1-IN-A01
  • HY-N0591
    Dehydrocostus Lactone

    去氢木香烃内酯

    Inhibitor 99.98%
    Dehydrocostus Lactone ((-)-Dehydrocostus lactone) 是一种可以从 Saussurea lappa 分离得到的天然倍半萜。Dehydrocostus Lactone 具有抗炎、抗菌、抗肿瘤和免疫调节等多种活性。Dehydrocostus Lactone 对 Mycobacterium tuberculosisMIC 为 2 µg/mL。Dehydrocostus Lactone 也可抑制细胞毒性 T 淋巴细胞杀伤活性,诱导肿瘤细胞凋亡 (apoptosis)。
    Dehydrocostus Lactone
  • HY-N0213
    Peiminine

    贝母素乙

    99.89%
    Peiminine 是一种可以从南瓜科 Bolbostemma paniculatum (Maxim) Franquet 中分离得到的化合物。Peiminin 可通过内源性和外源性凋亡途径诱导人肝癌 HepG2 细胞凋亡(apoptosis)。在许多动物模型中,Peiminin 具有抗炎、抗癌、抗骨质疏松、心肌保护等活性。
    Peiminine
  • HY-N0073
    Sarsasapogenin

    菝葜皂苷元

    Inhibitor 99.91%
    Sarsasapogenin 是从中草药知母中分离到的甾体皂苷元,具有抗糖尿病、抗氧化、抗癌、抗炎等多种功效。
    Sarsasapogenin
  • HY-N7088
    Raffinose

    棉子糖

    Inhibitor ≥98.0%
    Raffinose (Melitose) 可调节肠道菌群,抑制 TLR4-MyD88-NF-κB 信号通路,并激活 Nrf2 信号通路。Raffinose 具有抗炎、抗氧化和免疫调节活性。Raffinose 具有口服活性。
    Raffinose
  • HY-N1949
    Homoplantaginin

    高车前苷

    Inhibitor 99.90%
    Homoplantaginin是来自中药Salvia plebeia的具有抗炎和抗氧化活性的类黄酮。
    Homoplantaginin
  • HY-N2922
    β-Amyrin

    β-香树脂醇

    Inhibitor 99.95%
    β-Amyrin 能够有效对抗 β-淀粉样蛋白 (Aβ) 诱导的长时程增强 (LTP) 损伤,可用于阿尔茨海默病 (AD) 研究。β-Amyrin 有抗炎作用、抗肺纤维化以及显著的抗菌能力。β-Amyrin 是一种口服有效的天然三萜类化合物。
    β-Amyrin
  • HY-110261
    GS143 Inhibitor 99.09%
    GS143 是一种选择性的 IκBα 泛素化抑制剂,对于 SCFβTrCP1 介导的 IκBα 泛素化作用的 IC50 为 5.2 μM。GS143 抑制靶基因的 NF-κB 活化和转录,并且不抑制蛋白酶体的活性,并具有抗哮喘作用。
    GS143
  • HY-14806A
    Teneligliptin hydrobromide

    氢溴酸替格列汀

    Inhibitor 99.99%
    Teneligliptin (MP-513) hydrobromide 是一种口服活性的和选择性的 二肽基肽酶 4 (DPP-4) 抑制剂 (对人和大鼠酶的 IC50s 分别为 0.37 和 0.29 nM)。Teneligliptin hydrobromide 可改善血糖水平,可用于 2 型糖尿病相关的研究。
    Teneligliptin hydrobromide
  • HY-B0766
    Bicyclol

    双环醇

    Inhibitor 99.91%
    Bicyclol (SY801) 是一种具有口服活性的传统中药五味子的衍生物,具有多种生物活性,包括抗病毒、抗炎、免疫调节、抗氧化、抗脂肪变性、抗纤维化和抗肿瘤作用。Bicyclol 通过调节热休克蛋白的表达,发挥抗肝细胞凋亡 (apoptosis) 的作用,并抑制 ROS-MAPK-NF-κB 通路的激活,降低丙型肝炎病毒感染肝细胞中 NF-κB 的活化和炎症因子水平,从而预防急性肝损伤中的铁死亡 (Ferroptosis)。此外,Bicyclol 能够改变 Mdr-1、GSH/GSTBcl-2 的表达,提高细胞内抗癌药物浓度,使耐药细胞对抗癌药物增敏,同时调控 PI3K/AKTRas/Raf/MEK/ERK 通路,以抑制人恶性肝癌细胞的增殖。Bicyclol 适用于慢性肝炎、急性肝损伤、非酒精性脂肪性肝病、肝纤维化和肝细胞癌的研究。
    Bicyclol
  • HY-N6257
    Cafestol

    咖啡醇

    Inhibitor 99.91%
    Cafestol 是具有口服活性的二萜类化合物和 ERK2 的抑制剂。Cafestol 具有升高血脂、抗炎、抗血管生成和抗糖尿病的活性。此外,Cafestol 可诱导肿瘤细胞凋亡 (apoptosis) 和自噬 (autophagy),可用于癌症的研究。
    Cafestol
  • HY-N2534
    Karanjin

    水黄皮素

    Inhibitor 99.90%
    Karanjin 是一种具有口服活性的呋喃类黄酮,可从几种豆科植物中分离得到。Karanjin 具有明显的抗糖尿病、抗癌、抗炎、抗氧化、抗结肠炎、抗溃疡、抗阿尔茨海默病特性和多种驱虫/杀虫、杀螨特性,具有应用于相关研究的潜力。
    Karanjin
  • HY-128483
    Fusaric acid

    萎蔫酸

    Inhibitor 99.94%
    Fusaric acid 是一种口服有效的多通路抑制剂,具有诱导氧化应激和凋亡 (apoptosis) 的活性。Fusaric acid 可螯合二价金属阳离子、损伤线粒体膜结构,激活 Caspase-3/7、-8、-9 等凋亡相关蛋白酶。Fusaric acid 还调节 Bax/Bcl-2 蛋白,抑制 NF-κBTGF-β1/SMADsPI3K/AKT/mTOR 等纤维化相关信号通路,减少胶原沉积。Fusaric acid 也是一种多巴胺 β-羟化酶 (dopamine β-hydroxylase) 抑制剂,可降低脑、心脏、脾脏和肾上腺中去甲肾上腺素和肾上腺素的内源性水平。Fusaric acid 可在心脏疾病中发挥心肌纤维化、改善心脏肥厚的作用,还能够用于食管癌、肝癌等研究。
    Fusaric acid
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.